{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:01:34Z","timestamp":1777863694259,"version":"3.51.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study aimed to evaluate whether\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      resistance gene detection can independently guide antibiotic therapy for\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia in children and to identify key predictors for antibiotic adjustment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of children with\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia who underwent resistance gene testing. Participants were recruited from two centers (Affiliated Hospital of North Sichuan Medical College and People's Hospital of Nanbu County) between January 2023 and October 2025. Resistance gene testing results served as the basis for assigning patients to either the positive or negative group. The expression of\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      resistance genes was analyzed. The positive group was further divided into a \u201cswitch group\u201d (switched to doxycycline) and a \u201cmaintenance group\u201d (continued azithromycin). We performed a comparative analysis of demographic, clinical, and laboratory parameters across the groups. Multivariate logistic regression identified factors associated with switching antibiotics, and ROC curves assessed predictive performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 150 children were enrolled, with 13 in the macrolide resistance gene-negative group and 137 in the positive group, resulting in a macrolide resistance gene positivity rate of 91.3%. Of these patients\n                      <jats:bold>,<\/jats:bold>\n                      65 patients were in the switch group and 72 patients were in the maintenance group. Significant differences were observed in baseline characteristics (age), inflammatory markers (CRP, PCT, lymphocyte count), disease severity (severe MPP, pleural effusion, bronchoscopy), and clinical management (peak fever, hospital stay, antibiotic duration) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Logistic regression analysis identified increased age, elevated CRP, and prolonged hospital stay as independent predictors for switching to second-line antibiotics in macrolide-resistant\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the Nanchong area, macrolide resistance mediated by the 23S rRNA A2063G mutation predominates. Resistance gene detection alone indicates only potential resistance but cannot independently guide antibiotic switching. Among gene-positive children, elevated CRP and older age are early predictors of switching need, while prolonged hospital stay serves as a retrospective confirmatory marker. Clinical decisions should integrate these biomarkers rather than relying solely on genetic results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1785723","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:29:56Z","timestamp":1777526996000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Age, C-reactive protein, and hospital stay Are associated with switching from azithromycin to doxycycline in pediatric macrolide-resistant Mycoplasma pneumoniae pneumonia"],"prefix":"10.3389","volume":"14","author":[{"given":"Mengzhen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qirui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College","place":["Si Chuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, People\u2019s Hospital of Nanbu County","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1023\/a:1007353121693","article-title":"A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946\u20131995","volume":"13","author":"Lind","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/phmt.S473669","article-title":"Surge in Mycoplasma Pneumoniae infection and respiratory viruses co-infection in children with community-acquired pneumonia in the post-pandemic","volume":"15","author":"Chi","year":"2024","journal-title":"Pediatric Health Med Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2332680","DOI":"10.1080\/22221751.2024.2332680","article-title":"Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain","volume":"13","author":"Urbieta","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-023-00793-9","article-title":"Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen","volume":"20","author":"Zhang","year":"","journal-title":"World J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.19871\/j.cnki.xfcrbzz.2024.01.015","article-title":"Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023 edition)","volume":"9","author":"Zhao","year":"2024","journal-title":"Electron J Emerg Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3760\/cma.j.cn101070-20240817-00521","article-title":"Current status and research progress on macrolide-resistant Mycoplasma pneumoniae infection","volume":"40","author":"Li","year":"2025","journal-title":"Chin J Appl Clin Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1568005054880109","article-title":"Mechanisms of drug resistance in Mycoplasma pneumoniae","volume":"5","author":"B\u00e9b\u00e9ar","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12879-022-07715-6","article-title":"Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children","volume":"22","author":"Li","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1186017","DOI":"10.3389\/fcimb.2023.1186017","article-title":"Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae","volume":"13","author":"Wang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2010.03.004","article-title":"Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China","volume":"67","author":"Liu","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/jac\/dkr003","article-title":"Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children","volume":"66","author":"Chironna","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3201\/eid2609.191575","article-title":"Sequence type changes associated with decreasing macrolide-resistant Mycoplasma pneumoniae, Japan","volume":"26","author":"Morozumi","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1093\/jac\/dkaa256","article-title":"Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain","volume":"75","author":"Rivaya","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1181402","DOI":"10.3389\/fcimb.2023.1181402","article-title":"The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic","volume":"13","author":"Jiang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","article-title":"Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"20","author":"Wang","year":"2024","journal-title":"World J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e18810","DOI":"10.7717\/peerj.18810","article-title":"Clinical characteristics of pathogens in children with community-acquired pneumonia were analyzed via targeted next-generation sequencing detection","volume":"13","author":"Zhao","year":"2025","journal-title":"PeerJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2174\/0113862073364492250507095636","article-title":"Influence of Mycoplasma resistance genes on pediatric Mycoplasma pneumonia treatment and determinants for second-line antimicrobial adjustment","volume":"29","author":"Deng","year":"2026","journal-title":"Comb Chem High Throughput Screening"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/aac.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood\u2014time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"B22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B23","doi-asserted-by":"publisher","first-page":"107074","DOI":"10.1016\/j.ijid.2024.107074","article-title":"Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children: a clinical and epidemiological study in 2023 in Wuhan, China","volume":"145","author":"Dekyi, Xiao","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3969\/j.issn.1673-4130.2024.07.005","article-title":"Genomic analysis and drug resistance mechanisms of multidrug-resistant Citrobacter freundii","volume":"45","author":"Huang","year":"2024","journal-title":"Int J Lab Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"952636","DOI":"10.3389\/fmed.2022.952636","article-title":"Clinical evaluation of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid collected from children with community-acquired pneumonia","volume":"9","author":"Guo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"111503","DOI":"10.1016\/j.isci.2024.111503","article-title":"Risk factors and prescription patterns analysis for macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"27","author":"Lu","year":"2024","journal-title":"iScience"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.7499\/j.issn.1008-8830.2407129","article-title":"Analysis of multidrug resistance gene mutations and clinical significance in children with Mycoplasma pneumoniae pneumonia","volume":"26","author":"Zhang","year":"","journal-title":"Chin J Contemp Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/jcm11071782","article-title":"Recent trends in the epidemiology, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae","volume":"11","author":"Oishi","year":"2022","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/aac.01563-08","article-title":"Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China","volume":"53","author":"Xin","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/aac.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/aac.04308-14","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3969\/j.issn.1000-3606.2018.08.001","article-title":"Clinical characteristics of children with Mycoplasma pneumoniae pneumonia carrying the 23S rRNA A2063G mutation","volume":"36","author":"Li","year":"2018","journal-title":"J Clin Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/microorganisms12010218","article-title":"Novel knowledge of macrolide resistance in Mycoplasma pneumoniae by azithromycin exposure","volume":"12","author":"Oishi","year":"2024","journal-title":"Microorganisms"},{"key":"B34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"B35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/14740338.2024.2392865","article-title":"Systematic analysis of the adverse effects of commonly used clinical tetracycline drugs based on the FAERS database","volume":"24","author":"Xiong","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"B36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/aac.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients","volume":"15","author":"Matsubara","year":"2009","journal-title":"J Infect Chemother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3760\/cma.j.cn112140-20240728-00523","article-title":"Guidelines for the management of community-acquired pneumonia in children (2024 revision)","volume":"62","year":"2024","journal-title":"Chin J Pediatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.2147\/jir.S491981","article-title":"The clinical significance of pathogen loads and macrolide resistance levels for macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"17","author":"Leng","year":"2024","journal-title":"J Inflamm Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"811086","DOI":"10.3389\/fped.2022.811086","article-title":"Mycoplasma Pneumoniae infection and persistent wheezing in young children: a retrospective case-control study","volume":"10","author":"Sun","year":"2022","journal-title":"Front Pediatr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9328177","DOI":"10.1155\/2024\/9328177","article-title":"Clinical features and biomarkers for early prediction of refractory Mycoplasma Pneumoniae pneumonia in children","volume":"2024","author":"Chen","year":"2024","journal-title":"Emerg Med Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","article-title":"Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12890-021-01756-4","article-title":"Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children","volume":"21","author":"Li","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1515\/cclm-2022-1072","article-title":"How to best use procalcitonin to diagnose infections and manage antibiotic treatment","volume":"61","author":"Schuetz","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1128\/iai.01961-14","article-title":"Cytadherence of Mycoplasma pneumoniae induces inflammatory responses through autophagy and toll-like receptor 4","volume":"82","author":"Shimizu","year":"2014","journal-title":"Infect Immun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1038\/s41598-019-43617-5","article-title":"Activation of toll-like receptor 2 (TLR2) induces interleukin-6 trans-signaling","volume":"9","author":"Flynn","year":"2019","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.amjms.2016.02.032","article-title":"Community-Acquired pneumonia in patients with diabetes Mellitus: predictors of complications and length of hospital stay","volume":"352","author":"Bader","year":"2016","journal-title":"Am J Med Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/ppul.24327","article-title":"Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Yan","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13052-025-02039-y","article-title":"Prediction model for severe mycoplasma pneumoniae pneumonia and analysis of macrolide-resistance in children: a case-control study","volume":"51","author":"Liu","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","article-title":"A comparative study of general and severe mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-024-58784-3","article-title":"A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e23959","DOI":"10.1097\/md.0000000000023959","article-title":"A comparison of efficacy and safety of complementary and alternative therapies for severe mycoplasma pneumonia in children: a protocol for systematic review and meta-analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1785723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:30:02Z","timestamp":1777527002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1785723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":52,"alternative-id":["10.3389\/fped.2026.1785723"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1785723","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1785723"}}